======= SETD7 =======
== Gene Information ==
* **Official Symbol**: SETD7
* **Official Name**: SET domain containing 7, histone lysine methyltransferase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80854|80854]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8WTS6|Q8WTS6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SETD7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETD7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606594|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Histone methyltransferase that specifically monomethylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Plays a central role in the transcriptional activation of genes such as collagenase or insulin. Recruited by IPF1/PDX-1 to the insulin promoter, leading to activate transcription. Has also methyltransferase activity toward non-histone proteins such as p53/TP53, TAF10, and possibly TAF7 by recognizing and binding the [KR]-[STA]-K in substrate proteins. Monomethylates 'Lys-189' of TAF10, leading to increase the affinity of TAF10 for RNA polymerase II. Monomethylates 'Lys-372' of p53/TP53, stabilizing p53/TP53 and increasing p53/TP53-mediated transcriptional activation. {ECO:0000269|PubMed:12540855, ECO:0000269|PubMed:12588998, ECO:0000269|PubMed:15099517, ECO:0000269|PubMed:15525938, ECO:0000269|PubMed:16141209, ECO:0000269|PubMed:17108971}.
|SET|
|peptidyl-lysine monomethylation|
|peptidyl-lysine dimethylation|
|heterochromatin organization|
|histone-lysine N-methyltransferase activity|
|regulation of histone H3-K9 methylation|
|protein-lysine N-methyltransferase activity|
|regulation of histone methylation|
|p53 binding|
|histone lysine methylation|
|peptidyl-lysine methylation|
|histone methylation|
|chromosome|
|response to ethanol|
|protein methylation|
|protein alkylation|
|regulation of histone modification|
|regulation of chromatin organization|
|response to alcohol|
|macromolecule methylation|
|response to antibiotic|
|methylation|
|peptidyl-lysine modification|
|regulation of chromosome organization|
|histone modification|
|covalent chromatin modification|
|chromatin binding|
|response to toxic substance|
|chromatin organization|
|cellular response to DNA damage stimulus|
|nucleolus|
|peptidyl-amino acid modification|
|response to drug|
|chromosome organization|
|regulation of organelle organization|
|positive regulation of transcription, DNA-templated|
|response to oxygen-containing compound|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|cellular response to stress|
|positive regulation of RNA metabolic process|
|regulation of protein modification process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp210|LB-100 2μM R05 exp210]]|-2.07|
|[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.87|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.79|
|[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.71|
|[[:results:exp382|Palbociclib 1μM R07 exp382]]|1.71|
|[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|1.79|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|1.86|
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.9|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14738
* **Expression level (log2 read counts)**: 7.08
{{:chemogenomics:nalm6 dist.png?nolink |}}